LGD-3303
Muscle Building · SARM
Tier D+
What this is
Preclinical osteoporosis candidate from Ligand. Never advanced to clinical development. Exists in the research-chemical market primarily as a novelty; essentially no safety or efficacy information in humans.
Mechanism
Strong non-steroidal SARM from Ligand Pharmaceuticals — more androgenic than LGD-4033; bone and muscle anabolic in preclinical; no meaningful human trial program
Dose & route
No established human dosing
Citations
- https://pubmed.ncbi.nlm.nih.gov/19864487/
- https://pubmed.ncbi.nlm.nih.gov/21782036/
- https://pubmed.ncbi.nlm.nih.gov/29378245/
Links go to the source. If a link is dead or you want something re-checked, let me know.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.